STRO
Price
$0.73
Change
-$0.07 (-8.75%)
Updated
Jun 27 closing price
Capitalization
64.81M
39 days until earnings call
TCRX
Price
$1.40
Change
-$0.08 (-5.41%)
Updated
Jun 27 closing price
Capitalization
79.23M
45 days until earnings call
Interact to see
Advertisement

STRO vs TCRX

Header iconSTRO vs TCRX Comparison
Open Charts STRO vs TCRXBanner chart's image
Sutro Biopharma
Price$0.73
Change-$0.07 (-8.75%)
Volume$11.76M
Capitalization64.81M
TScan Therapeutics
Price$1.40
Change-$0.08 (-5.41%)
Volume$5.4M
Capitalization79.23M
STRO vs TCRX Comparison Chart in %
Loading...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STRO vs. TCRX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (STRO: $0.73 vs. TCRX: $1.40)
Brand notoriety: STRO and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 739% vs. TCRX: 811%
Market capitalization -- STRO: $64.81M vs. TCRX: $79.23M
STRO [@Biotechnology] is valued at $64.81M. TCRX’s [@Biotechnology] market capitalization is $79.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 3 bullish TA indicator(s).

  • STRO’s TA Score: 3 bullish, 6 bearish.
  • TCRX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both STRO and TCRX are a bad buy in the short-term.

Price Growth

STRO (@Biotechnology) experienced а -7.53% price change this week, while TCRX (@Biotechnology) price change was -2.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

STRO is expected to report earnings on Aug 07, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($79.2M) has a higher market cap than STRO($64.8M). TCRX YTD gains are higher at: -53.947 vs. STRO (-60.109). TCRX has higher annual earnings (EBITDA): -124.58M vs. STRO (-203.18M). TCRX (252M) and STRO (249M) have equal amount of cash in the bank . STRO has less debt than TCRX: STRO (21.4M) vs TCRX (97M). STRO has higher revenues than TCRX: STRO (66.4M) vs TCRX (4.42M).
STROTCRXSTRO / TCRX
Capitalization64.8M79.2M82%
EBITDA-203.18M-124.58M163%
Gain YTD-60.109-53.947111%
P/E RatioN/AN/A-
Revenue66.4M4.42M1,502%
Total Cash249M252M99%
Total Debt21.4M97M22%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STROTCRX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NHYKF5.760.11
+2.04%
Norsk Hydro ASA
ACOPF5.10N/A
N/A
A2 Milk Co Ltd.
HLYK0.02N/A
N/A
HealthLynked Corp.
DSBX15.20N/A
N/A
Dogwood State Bank RALEIGH NC
BKFAF7.01N/A
N/A
BROOKFIELD CORP.

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with TRDA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-8.14%
TRDA - STRO
41%
Loosely correlated
-1.57%
ATXS - STRO
40%
Loosely correlated
N/A
DNLI - STRO
39%
Loosely correlated
-2.69%
TCRX - STRO
39%
Loosely correlated
-5.41%
PDSB - STRO
39%
Loosely correlated
-2.76%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-5.41%
FATE - TCRX
46%
Loosely correlated
-5.45%
CRBU - TCRX
44%
Loosely correlated
-5.19%
MGNX - TCRX
44%
Loosely correlated
-6.30%
IMNM - TCRX
43%
Loosely correlated
-0.23%
EYPT - TCRX
41%
Loosely correlated
-7.04%
More